After different contacts along 2013, last month ReadyCell visited several companies during a Chinese tour. With the aim to promote its implantation in the Asian market, and being a hub for R&D and CRO services, Shanghai and Beijing were the cities chosen for this partnering trip.
ReadyCell representatives met CEOs, CSOs and ADME Directors from key Chinese companies as Wuxi App Tec, Joinn Laboratories, Shanghai Medicilon and PharmaLegacy. Thanks to ReadyCell strategic partner Link China Pharma, several top Chinese CROs are actually evaluating Ready-to-Use kits for their implantation in their Permeability assays.
Implantation of ReadyCell kits in Asia (China and India) as regular supplier is expected to be set up for 2014 Q3, as part of the company strategic plan for this year.